Inhibikase Therapeutics
IKT
IKT
9 hedge funds and large institutions have $975K invested in Inhibikase Therapeutics in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$107K | |
| 2 | +$69K | |
| 3 | +$67K | |
| 4 |
BlackRock
New York
|
+$3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3K |